含（1—芳乙酰胺基—2—叔胺基）乙烷结构的六氢—1H—1，4—二氮Zhuo类新化合物的合成（Ⅰ）

合成了N,N′－二苄基－2－甲氧羰基－六氢－1H－1,4－二氮Zhuo（3）。3经还原、氯取代、胺取代、胺脱苄、单酰化及酰化反应后得到了10个带有（1－久乙酰胺基－2－叔氨基）乙烷结构的六氢－1H－1,4－二氮Zhuo类目标化合物（9a-9i和10）。     

喹啉酮衍生物的合成及其心血管活性

异黄酮化合物具有心血管活性[1],雌激素活性[2]及抗骨质疏松[3]活性等。3 苯基 4(1Ｈ)喹啉酮衍生物是异黄酮化合物的等电子体,文献报道它具有与异黄酮化合物相似的心血管活性[4]和抗肿瘤[5]活性。结构中具有氟原子的化合物大多能改善脂溶性,增强生理活性,且能选择性作用于脑细胞及脑血管;喹诺酮类抗菌药中具有优良抗菌活性的化合物几乎都含有氟原子。我们对含氟的3 苯基 4(1Ｈ)喹啉酮类化合物进行了研究。以氟氯苯胺为原料,合成了其7 氯衍生物(化合物Ａ1～Ａ4),及5 氯衍生物(化合物Ｂ1～Ｂ4),其中7 氯衍生物为主产物,合成路线如下:化合…     

3－嘧啶胺基或三嗪胺基甲酰基－4－羟基－2H－1，2－苯并噻嗪－1，1－二氧化物的合成及活性

通过３－乙氧甲酰基－４－羟基－２－氢（甲基）－２Ｈ－１，２－苯并噻嗪－１，１－二氧化物与取代嘧啶胺或均三嗪胺的胺解反应，合成了标题化合物。生物活性测定结果表明多数化合物具有较好的除草活性，部分化合物显示好的植物生长调节活性和抗炎免疫活性。     

5-取代苯氨基-6-甲基-1,2,4-三嗪-3-硫酮的合成

含有 1 ,2 ,4 三嗪结构的化合物具有广泛的生理活性。我们曾用α 乙酰基硫代甲酰芳胺为原料 ,合成了一系列三嗪类和其它杂环化合物 ,其中1 ,2 ,4 三嗪类有 4,6 二取代 5 硫酮 1 ,2 ,4三嗪 3 酮[1 ,2 ] ,3 氨基 5 取代苯氨基 6 苯基 1 ,2 ,4 三嗪[3] 等化合物。本文以α 乙酰基硫代甲酰芳胺为原料 ,进一步合成 5 取代苯氨基 6 甲基 1 ,2 ,4 三嗪 3 硫酮。当乙酰基硫代甲酰芳胺 1 (ａ ｇ)与氨基硫脲 2反应时 ,首先生成缩氨基硫脲 3(ａ ｇ) ,然后环化得到 5 取代苯氨基 6 甲基 1 ,2 ,4 三嗪 3硫酮 4(ａ ｇ) ,合成中发现 ,4(ａ ｇ)可…     

1-取代-4,5-二(4-氯苯基)咪唑的合成和结构表征

合成了6种1-取代-4,5-二(4-氯苯基)咪唑.以对氯苯乙酸和氯苯为原料,经Friedel-Crafts酰基化反应、二氧化锡氧化、与多聚甲醛和乙酸铵环合制备了中间体4,5-二(4-氯苯基)咪唑(5),5再经取代得到3个1-取代-4,5-二-(4-氯苯基)咪唑类化合物6a-c.6a再分别与液体胺经亲核取代反应得到3个1-取代乙酰胺类-4,5-二-(4-氯苯基)咪唑类化合物7a-c.目标化合物结构用核磁共振氢谱和红外光谱进行了表征.     

氟芳胺基、氟磺酰胺基磷酸酯的合成

首次合成了氟芳胺基磷酸酯和氟磺酰胺基磷酸酯.对氟苯胺、α-氯-4-三氟甲基吡啶胺、α-氯-4-三氟甲基氧化吡啶胺与二乙氧基磷酰氯在乙腈或DMF中反应,得到氟芳胺基磷酸酯.氟烷基磺酰甲胺与二乙氧基磷酰氯反应,以金属钠处理,相应钠盐在乙腈或DMF中,于室温下反应将得到氟烷磺酰胺基磷酸酯.     

3-(3-吡啶基)-4-氨基-5-芳胺基-1,2,4-三唑的合成与表征

以烟酸与芳胺为基本原料，经多步反应，制得1－烟酰基－4－芳基氨基硫脲；后者在水合肼存在下关环，合成了一系列新化合物3－（3－吡啶基）－4－氨基－5－芳胺基－1，2，4－三唑。化合物结构经元素分析、IR，^1H NMR,^13C NMR确证。     

N－取代－6－芳硫基吡啶酮类化合物的合成与生物活性研究

以3－羟基－2－烷基－4（1H）－吡喃酮为原料与胺反应制备N－取代－4（1H ）－吡啶酮，再与亲核试剂发生氧化－迈克尔加成反应，合成了相应的N－取代－ 6－芳硫基吡啶酮化合物。生物活性研究结果发现，N－取代－6－芳硫基吡啶酮类 化合物对5－脂氧合酶具有良好的抑制作用。     

具有生物活性的有机磷化合物的研究Ⅶ．4－（喹噁啉－2－氧基）苯基烷基N－烷基磷酰胺酯的合成与性质

烷基磷酰二氯分别与４－（喹啉－２－氧基）苯酚钠和仲胺在极性有机溶剂中亲核取代反应合成了８种新的标题化合物，其结构用元素分析，红外光谱，核磁共振谱及质谱进行了表征，并测定了它们的除草活性。     

2-取代-3,4-二氢-1-异喹啉酮的合成和舒张血管活性

以3-羟基-4-甲氧基苯甲酸甲酯等为原料, 通过烯丙基醚化、Claisen重排、氧化、与伯胺反应(生成Schiff碱)、还原、分子内酯的胺解六步反应合成了一系列2-取代-3,4-二氢-1-异喹啉酮类化合物. Schiff碱的制备、还原、酯的胺解三步在“一锅”内完成. 采用1H NMR, MS和元素分析对目标化合物的结构进行了表征. 离体动脉环张力实验证明此类化合物具有明显舒张血管的作用.     

Synthesis and Anti-HIV-1 Activity of 2-[2-(3,5-Dimethylphenoxy)ethylthio]pyrimidin-4(3H)-ones

New 2-[2-(3,5-dimethylphenoxy)ethyl]thio derivatives of pyrimidin-4(3H)-one containing various substituents at positions 5 and 6 of the pyrimidine ring were synthesized. It was shown that alkylation of 2-thiouracils with 1-bromo-2-(3,5-dimethylphenoxy)ethane in DMF takes place exclusively at the sulfur atom. The obtained 6-benzyl and 6-(2,6-difluorobenzyl) derivatives have clearly defined virus-inhibiting properties with respect to type 1 human immunodeficiency virus in vitro and suppress its reproduction by 50% at concentrations of 1.3 and 11.2 mM respectively.     

荧光探针5-羰基咪唑苯并吖啶酮的合成及其LC-APCI-MS法测定胺

在不加任何催化剂条件下, 2-(12-苯并吖啶酮)-乙酸(BAAA)与N,N′-羰基双咪唑(CDI)缩合生成新型荧光探针5-羰基咪唑苯并吖啶酮(IEBA). IEBA在DMF溶剂中与胺类化合物形成的酰胺类衍生物不仅可发出强烈的荧光, 还具有较高的质谱离子化能力. 该衍生物在乙腈和甲醇-水溶液中的百分离子化δ值分别在0~57.32% 和0~62.14%范围内. 最大激发和发射波长λex/λem=272 nm/505 nm. 12种胺类衍生物的荧光检出限范围为0.15~0.50 ng/mL, 在线APCI-MS检出限范围为1.43~8.51 ng/mL.     

藏药柳茶叶乙醇水提取物中化学成分的鉴定

采用多种色谱分离技术对藏药柳茶叶80%乙醇提取物进行分离纯化,得到了9个化合物。 根据其理化性质与NMR谱数据对化合物进行了结构鉴定,分别为金丝桃苷（hyperoside,Ⅰ）、槲皮素（quercetin,Ⅱ）、芸香苷（rutin,Ⅲ）、槲皮素3-O-β-D-吡喃葡萄糖苷（quercetin-3-O-β-D-glucopyranoside,Ⅳ）、儿茶素（catechin,Ⅴ）、香草酸（vanillic acid,Ⅵ）、熊果苷（arbutin,Ⅶ）、异阿魏酸（isoferulic acid,Ⅷ）和胡萝卜苷（daucosterol,Ⅸ）。 化合物中除Ⅳ、Ⅷ和Ⅸ外,其余6个化合物为首次从该属植物中分离鉴别。     

Synthesis of New Naphthaline-type Chromophores with Strong Green-emitting or the Blue-emitting in β-Cyclodextrin

Three new naphthaline-type chromophores end-capped with different (p-substituted amino) styryl groups on the both sides (named as BPASN, BHMASN and BMASN) have been synthesized. Under excitation of 380nm, strong green light-emitting locating at 517nm with the fluorescence quantum yield of 0.88 in CH2Cl2 has been obtained.In the presence of β-cyclodextrin (β-CD), strong blue-emitting at 456nm in DMF was also recorded.     

Synthesis and Crystal Structure of 1-（4-Fluorophenyl）-2-hexylthiobenzo[4,5]-furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5（1H）-one

The crystal structure of the title compound 1-(4-fluorophenyl) -2-hexylthio-benzo [4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5(1H) -one(C23H21FN4O2S,Mr = 436.5) has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic,space group P21/n with a = 13.9854(3) ,b = 17.2678(4) ,c = 18.1828(5) ,β = 99.364(2) °,V = 4332.58(18) 3,Z = 4,Dc = 1.338,F(000) =1824,μ = 0.185 mm-1,MoKa radiation(λ = 0.71073) ,R = 0.0538 and wR = 0.1162 for 4728 observed reflections with I > 2σ(I) . X-ray diffraction analysis reveals the fused rings of benzo[4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a] pyrimidin-5(1H) -one system are nearly coplanar. The crystal packing is mainly stabilized by weak intermolecular C-H···O hydrogen bond and π-π interactions.     

莽吉柿中几种双苯吡酮和蒽醌类成分的分离与鉴定

对莽吉柿(Pericarpium Garciniae Mangostanae)85%乙醇提取物进一步分离,得到8个双苯吡酮类化合物和1个蒽酮类化合物,经理化性质和NMR及MS谱学数据鉴定分别为α-倒捻子素-3,6-二乙酸酯（α-mangostin-3,6-diyl diacetate,Ⅰ）、1,5,8-三羟基-3-甲氧基-2,4-双-（3-甲基丁-2-烯）双苯吡酮（8-hydroxycudraxanthone G,Ⅱ）、1,3-二羟基-6,7-二甲氧基-2,8-双-（3-甲基丁-2-烯基）双苯吡酮（Cowaxanthone B,Ⅲ）、1,6-二羟基-3,5-二甲氧基-2-（3-甲基丁-2-烯基）双苯吡酮（Cowaxanthone A,Ⅳ）、1,5-二羟基-4-（3-甲基丁-2-烯基）-6′,6′-二甲基吡喃[2′,3′:3,2]双苯吡酮（trapezifolixanthone,Ⅴ）、1,6-二羟基-6′,6′-二甲基吡喃[2′,3′:7,8]-6″,6″-二甲基吡喃[2″,3″:3,2-]双苯吡酮（brasilixanthone B,Ⅵ）、1,3,5-三羟基-2-（3-甲基丁-2-烯）-4-（1,1-二甲基-2-烯丙基）双苯吡酮（Allanxanthone A,Ⅶ）、1,3,8-三羟基-5-甲氧基-2,4-双-（3-甲基丁-2-烯）双苯吡酮(2,4-di-(3-methylbut-2-enyl)-1,3,8-trihydroxy-5-methoxyxanthone,Ⅷ)、1,4,8-三羟基-6-甲基-3-甲氧基-9,10-蒽酮(1,4,8-trihydroxy-6-methyl-3-methoxy- 9,10-anthraquinone, Ⅸ）。 其中化合物Ⅰ、Ⅴ、Ⅵ、Ⅶ、Ⅸ为首次从藤黄属植物中分离得到,化合物Ⅱ、Ⅲ、Ⅳ、Ⅷ为首次从该植物中分离得到。     

Facile synthesis and characterization of novel pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-one and pyrido[2′,3′:3,4]pyrazolo[1,5-a]pyrimidine incorporating 1,3-diarylpyrazole moiety

4-(3-(4-Hydroxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-6-phenyl-2-thioxo-1,2-di hydro-pyridine-3-carbonitrile (1) reacted with ethyl chloroacetate (2) in ethanolic sodium acetate solution to yield the corresponding ethyl (3-cyanopyridin-2-ylsulphanyl)acetate derivative 3. Intramolecular cyclization of compound 3 was achieved by its heating in DMF containing potassium carbonate to afford the corresponding ethyl 3-aminothieno[2,3-b]pyridine-2-carboxylate derivative 4 which reacted with hydrazine hydrate in refluxing pyridine to yield the starting material 3-aminothieno[2,3-b]pyridine-2-carbohydrazide derivative 7. Compound 7 reacted with different reagents such as triethylorthoformate, formic acid, acetic acid and acetic anhydride to afford the target molecules pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-one derivatives 8–10, 12 and 13 in good to excellent yields. On the other hand, pyridine-2(1H)-thione derivative 1 reacted with hydrazine hydrate in refluxing pyridine to give the other starting material 3-amino-1H-pyrazolo[3,4-b]pyridine derivative 20 which reacted with acetylacetone under reflux to afford the target molecule pyrido[2′,3′:3,4]pyrazolo[1,5-a]-pyrimidine derivative 21 in a good yield. The structures of target molecules were elucidated using elemental analyses and spectral data.     

ZrOCl2·8H2O as an efficient and recyclable catalyst for the one‐pot multicomponent synthesis of novel [1,3]oxazino[5,6‐c]quinolin‐5‐one derivatives

A simple, efficient and eco‐friendly procedure has been developed using ZrOCl₂·8H₂O as catalyst for the synthesis of novel [1,3]oxazino[5,6‐c]quinolin‐5‐one derivatives in aqueous ethanol at room temperature. The present methodology offers several advantages such as operational simplicity, use of ZrOCl₂·8H₂O as a green, non‐toxic, inexpensive and reusable catalyst, reusability of reaction media, high yields, mild and environmentally benign reaction conditions.     

Synthesis,Reactions, and Structure of 5-Cyano-4-ethoxy-1-ethoxycarbonyl-2-methylazuleno[1,8-b,c]pyran

Bicyclic azulene compounds, ethyl 4-(cyanoethoxycarbonylmethyl)-2-methylazulene-1-carboxylate (2) and ethyl 4-(cyanoethoxycarbonylmethyl)azulene-1-carboxylate (3) were prepared from ethyl 4-chloro-2-methylazulene-1-carboxylate (7) and ethyl 4-ethoxyazulene-1-carboxylate (8), respectively. Oxidation of 2 with DDQ gave the title compound, 5-cyano-4-ethoxy-1-ethoxycarbonyl-2-methylazuleno[1,8-b,c]pyran (1) and a minor compound, ethyl 4-cyanomethyl-2-methylazulene-1-carboxylate (9). Oxidation of 3 by DDQ produced only ethyl 4-cyanomethylazulene-1-carboxylate (10), Reaction of 1 with 100% H₃PO₄ at room temperature and 100 °C gave 5-cyano-4-ethoxy-2-methylazuleno[1,8-b,c]pyran (11) and 2-methyl-4,5-dihydrozuleno[1,8-b,c]pyran-4-one (12), respectively. All the new compounds were characterized by IR, UV-vis, NMR and Mass spectra, and the structure of 1 was determined by X-ray crystallography. Crystal data for 1; space group P2₁/n, a = 7.391(1), b = 9.660(5), c = 22.859(1) Å, B = 97.01(1)°, V = 1620.0(3) ų, Z = 4, with final residuals R = 0.047 and Rw = 0.055.     

新型吡唑并嘧啶并吡唑三元稠合化合物的合成

Novel fused heterotricyclic compounds 3—6 containing two different dipyrazolopyrimidine framework were prepared from 1a—1d. The reaction of 1 with K2CO3 in DMSO or NaH in DMF led to the formation of 2 or 3, respectively, which reacted further to afford 6 or 5, respectively.